Aurora Spine (CVE:ASG) Stock Falls 16.7% – Should You Sell?

Aurora Spine Co. (CVE:ASG – Get Free Report) shares dropped 16.7% during mid-day trading on Monday. The stock traded as low as C$0.10 and last traded at C$0.10. 164,021 shares changed hands during trading, an increase of 384% from the average daily volume of 33,859 shares. The stock had previously closed at C$0.12.

Aurora Spine Stock Performance

The firm’s 50-day moving average price is C$0.14 and its 200-day moving average price is C$0.23. The company has a debt-to-equity ratio of 76.80, a current ratio of 2.25 and a quick ratio of 1.40. The stock has a market cap of C$7.81 million, a P/E ratio of -10.00 and a beta of 0.07.

Aurora Spine Company Profile

(Get Free Report)

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc, engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process.

Featured Articles

Receive News & Ratings for Aurora Spine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Spine and related companies with MarketBeat.com's FREE daily email newsletter.